The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis C

BACKGROUND: It has been found that ITPase deficiency is caused by ITPA gene polymorphisms. It was observed that ITPA polymorphisms have impact on hematological changes, including hemoglobin (Hb)-decline during treatment of chronic hepatitis C (CHC) patients with pegylated-interferon (PEG-IFN) plus r...

Descripción completa

Detalles Bibliográficos
Autores principales: Pouryasin, Mohammad, Keshvari, Maryam, Sharafi, Heidar, Alavian, Seyed Moayed, Behnava, Bita, Alavian, Seyed Ehsan, Pouryasin, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851836/
https://www.ncbi.nlm.nih.gov/pubmed/27148387
http://dx.doi.org/10.5812/hepatmon.35278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851836/
https://www.ncbi.nlm.nih.gov/pubmed/27148387
http://dx.doi.org/10.5812/hepatmon.35278

Ejemplares similares